The Potential of PSMA as a Vascular Target in TNBC

14Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

Recent studies proving prostate-specific membrane antigen (PSMA) expression on triple-negative breast cancer (TNBC) cells and adjacent endothelial cells suggest PSMA as a promising target for therapy of until now not-targetable cancer entities. In this study, PSMA and its isoform expression were analyzed in different TNBC cells, breast cancer stem cells (BCSCs), and tumor-associated endothelial cells. PSMA expression was detected in 91% of the investigated TNBC cell lines. The PSMA splice isoforms were predominantly found in the BCSCs. Tumor-conditioned media from two TNBC cell lines, BT-20 (high full-length PSMA expression, PSMAΔ18 expression) and Hs578T (low full-length PSMA expression, no isoform expression), showed significant pro-angiogenic effect with induction of tube formation in endothelial cells. All TNBC cell lines induced PSMA expression in human umbilical vein endothelial cells (HUVEC). Significant uptake of radiolabeled ligand [68Ga]Ga-PSMA was detected in BCSC1 (4.2%), corresponding to the high PSMA expression. Moreover, hypoxic conditions increased the uptake of radiolabeled ligand [177Lu]Lu-PSMA in MDA-MB-231 (0.4% vs. 3.4%, under hypoxia and normoxia, respectively) and MCF-10A (0.3% vs. 3.0%, under normoxia and hypoxia, respectively) significantly (p < 0.001). [177Lu]Lu-PSMA-induced apoptosis rates were highest in BT-20 and MDA-MB-231 associated endothelial cells. Together, these findings demonstrate the potential of PSMA-targeted therapy in TNBC.

References Powered by Scopus

Triple-negative breast cancer: Clinical features and patterns of recurrence

3998Citations
N/AReaders
Get full text

VEGF in Signaling and Disease: Beyond Discovery and Development

1850Citations
N/AReaders
Get full text

ROS in cancer therapy: the bright side of the moon

1521Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Head-to-Head Comparison of [<sup>18</sup>F]PSMA-1007 and [<sup>18</sup>F]FDG PET/CT in Patients with Triple-Negative Breast Cancer

9Citations
N/AReaders
Get full text

CAR-based immunotherapy for breast cancer: peculiarities, ongoing investigations, and future strategies

5Citations
N/AReaders
Get full text

Theranostics in breast cancer

4Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Heesch, A., Ortmanns, L., Maurer, J., Stickeler, E., Sahnoun, S. E. M., Mottaghy, F. M., & Morgenroth, A. (2023). The Potential of PSMA as a Vascular Target in TNBC. Cells, 12(4). https://doi.org/10.3390/cells12040551

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 3

50%

Researcher 3

50%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 5

63%

Pharmacology, Toxicology and Pharmaceut... 2

25%

Agricultural and Biological Sciences 1

13%

Article Metrics

Tooltip
Mentions
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free